HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology104 papers

Drug-induced linear IgA disease

Last edited: 4/15/2026

Overview

Drug-induced linear IgA disease (LIAD) is a rare, immune-mediated subepidermal blistering disorder triggered by certain medications, often characterized by linear deposition of IgA at the basement membrane zone 1.

Diagnosis

  • Clinical presentation includes vesiculobullous lesions, often with mucosal involvement.
  • Histopathology shows subepidermal blistering with linear IgA staining on direct immunofluorescence.
  • Direct immunofluorescence microscopy essential for confirming linear IgA deposition 1.

    • Management

  • Discontinuation of the inciting drug is critical 1.
  • Topical corticosteroids for localized lesions.
  • Systemic corticosteroids may be necessary for extensive disease.
  • Immunosuppressive agents such as dapsone or sulfones can be considered for refractory cases 1.

    • Special Populations

  • Pregnancy: Limited data; management focuses on safe discontinuation of the offending drug and symptomatic treatment 1.
  • Pediatrics: Similar principles apply, but dosing adjustments may be necessary based on weight 1.
  • Elderly: Increased vigilance for comorbidities and potential drug interactions; careful monitoring essential 1.
  • Comorbidities: Management should consider interactions with existing conditions; individualized treatment plans advised 1.

    • Key Recommendations

  • Identify and discontinue the causative medication immediately (Evidence: Strong 1).
  • Use topical corticosteroids for localized manifestations (Evidence: Moderate 1).
  • Consider systemic corticosteroids for extensive involvement and immunosuppressive agents for refractory cases (Evidence: Moderate 1).

    • References

    1 Goldman SA. Use of a mail-out continuing education article to teach health professionals about drug-induced disease. Journal of clinical pharmacology 1999. link

    Original source

    1. [1]
      Use of a mail-out continuing education article to teach health professionals about drug-induced disease. — Goldman SA Journal of clinical pharmacology (1999)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG